Whilst p-tau is the defining feature of CTE neuropathology, non-aggregate pathologies such as neuroinflammation, axonal damage, and vascular changes are known to have pivotal roles in other neurodegenerative tauopathies such as AD and in post-traumatic sequelae, highlighting their potential for large contributors to CTE neuropathology. This evidence concerns the gene MAPT and Alzheimer disease.